The US Food and Drug Administration (USFDA)
Unless you live in a cave without television, you should already know the name Fauci.
Fenbendazole is not yet approved by the FDA or the EMA (Europe) for human use, and there have not been any phase III Clinical Trials. Fenbendazole is not listed by the World Health Organization (WHO) for human use.
FDA-approved or not, people around the world need access to detailed information about products and treatments that cure the underlying disease, not just treat its symptoms. Tell your doctor to make Fenbendazole and Mebendazole an approved course of treatment in humans for cancer.
In 1980, Anthony Stephen Fauci was appointed the new chief of the NIAID’s Laboratory of Immunoregulation. In 1984, he became the director of the National Institute of Allergy and Infectious Diseases (NIAID) and served in that role until 2022. Unless you live in a cave without television, you should already know the name Fauci.
As head of the NIAID, he oversaw research on how to prevent, diagnose, and treat infectious diseases, including HIV/AIDS. In the 1980’s, an AIDS epidemic gripped America. In 1987, AZT (zidovudine) became the first drug approved by the FDA to treat AIDS.
Burroughs-Wellcome filed for a patent for AZT in 1985 and released the drug, branded as Retrovir, in 1987 through Wellcome PLC. This made AZT the first successful treatment for AIDS. According to a study by Thomas McLaughlin, Harvard Medical School, cumulative worldwide sales of AZT generated about $1.3 billion in unadjusted profits for Burroughs Wellcome from 1987 to 1996.
BURROUGHS WELLCOME AZT AFTER-TAX PROFITS PROJECTED AT $1.3 BIL. https://insights.citeline.com/PS022838/BURROUGHS-WELLCOME-AZT-AFTERTAX-PROFITS-PROJECTED-AT-13-BIL/
Pricing Retrovir: Wellcome PLC and the Role of Pharmaceutical Companies in the Global AIDS Crisis, 1986 to 1991 https://pubmed.ncbi.nlm.nih.gov/35788340/
Anyone opposing the government’s FDA-approved treatment option or suggesting alternatives was litigated, prosecuted, and publicly declared a nut. A powerful example of this suppression was the life of Texas electrician Ronald Dickson Woodroof (February 3, 1950 – September 12, 1992)
After learning he had contracted the human immunodeficiency virus (HIV) in 1985 and being diagnosed with AIDS, he created a group as part of his efforts to find and distribute drugs to treat AIDS at a time when the disease was poorly understood.
Ron Woodroof Biography | Pantheonc https://pantheon.world/profile/person/Ron_Woodroof
After suffering from the side effects of AZT, Ron Woodroof began looking for other drugs he could use to further prolong his life. He acquired nutritional supplements and drugs not approved by the FDA for use in the United States, which he found helpful in ameliorating his symptoms.
Ron Woodroof - Wikipedia https://en.wikipedia.org/wiki/Ron_Woodroof
In 1988, Ron created an organization that would become known as the Dallas Buyers Club. The group was part of his efforts to find and distribute outside unsanctioned applications and drugs to treat AIDS. The FDA and the government fought him at every turn.
As Ron(s) ... business grows, the Dallas Buyers Club becomes the subject of frequent raids by the FDA, DEA, and local police - with the entire inventory subject to confiscation.
The Life and Times of Ron Woodroof https://www.focusfeatures.com/article/the_life_and_times_of_ron_woodroof
Some of what Ron offered yielded no results. However, some of his alternative treatments were life-extending miracles. None were FDA-approved. Prosecutors, the FDA, and the government targeted Ron for recommending non-FDA-approved treatments.
The 2013 Hollywood movie Dallas Buyers Club illustrates Ron’s struggle. https://www.imdb.com/title/tt0790636/
The definitive look at the unlicensed AIDS drug movement is a book called “Acceptable Risks” by Jonathan Kwitny. *http://www.amazon.com/Acceptable-Risks-Jonathan-Kwitny/dp/0671732447
A more recent example of possible government suppression occurred during the COVID-19 pandemic. Fauci (the same millionaire government bureaucrat) pushed a new COVID-19 treatment called Remdesivir. It was developed and patented by the American biopharmaceutical company Gilead Sciences. Remdesivir is a broad-spectrum antiviral medication. During the COVID‑19 pandemic, Remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries. It is important to note the following fact:
Under section 564(c)(3) of the FD&C Act, an EUA may be issued only if FDA concludes there is no adequate, approved, and available alternative to the product for diagnosing, preventing, or treating the disease or condition.
Revocation of Emergency Use of a Drug During the COVID-19 Pandemic; Availability
The USFDA fully approved remdesivir on October 22, 2020.
On May 1, 2020, the FDA issued an Authorization (EUA 046) for remdesivir to Gilead, subject to the terms of the Authorization. Notice of the issuance of the Authorization was published in the Federal Register on September 11, 2020 (85 FR 56231), as required by section 564(h)(1) of the FD&C Act. Subsequent amendments to the Authorization on August 28, 2020; October 1, 2020; October 16, 2020; October 22, 2020; and January 21, 2022 were made available on the FDA’s website.
Revocation of Emergency Use of a Drug During the COVID-19 Pandemic; Availability
Both treatments, AZT and Remdesivir, enriched big pharma. Gilead Sciences Inc reported a 17% rise in quarterly revenue, helped by sales of its antiviral drug Remdesivir, the first and only treatment approved in the United States for patients hospitalized with COVID-19.
Gilead cuts 2020 sales outlook as COVID-19 drug remdesivir falls short - Reuters https://forbes.ge/gilead-cuts-2020-sales-outlook-as-covid-19-drug-remdesivir-falls-short-reuters/
Regardless of whether you had a successful alternative treatment, both drugs AZT and Remdesivir were singled out by the government as the only “FDA-approved treatment.” Anyone touting something different came under attack by the government, the mainstream media, and social media tech companies.
However, during the COVID-19 pandemic, safe alternatives, such as Ivermectin, emerged that were not approved by the government as COVID-19 treatments. They were FDA-approved drugs, but not approved for use in the treatment or prevention of COVID-19.
Although proven to be successful in treating Covid-19, off-patent and cheap Ivermectin could never make big money for the pharma industry. This proven and widely available drug was purposefully ignored and demonized by the established medical community in the United States.
According to the United States Food and Drug Administration (4/05/24)
One of the U.S. Food and Drug Administration’s jobs is to carefully evaluate the scientific data on a drug to be sure that it is both safe and effective for a particular use.
There continues to be interest in a drug called ivermectin for the prevention or treatment of COVID-19 in humans. The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals.
For humans, ivermectin tablets are approved at specific doses to treat some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. For animals, certain pour-on, injectable, paste, chewable, and “drench” ivermectin products are approved in the U.S. for the treatment or prevention of parasites.
FDA: Ivermectin and COVID-19 – emergencymessagesystem.com https://emergencymessagesystem.com/fda-ivermectin-and-covid-19/